Role of vitamin D serum levels in prevention of primary and recurrent melanoma
Sci Rep . 2021 Mar 12;11(1):5815. doi: 10.1038/s41598-021-85294-3.
M Lombardo 1, A Vigezzi 2, G Ietto 3, C Franchi 3, V Iori 3, F Masci 3, A Scorza 3, S Macchi 3, D Iovino 3, C Parise 3, G Carcano 3
- Overview Suntan, melanoma and vitamin D
- Sunlight on skin has decreased 9X while melanoma has increased 30X – Feb 2020
- Melanoma 2.1 X more likely if low vitamin D – meta-analysis Jan 2020
- Melanoma 25 X more likely if low vitamin D – Feb 2018
- Melanoma cancer growth slowed by increased Vitamin D Receptor (yet again) – Oct 2019
- Melanoma Is a Disease of Office Workers - Dec 2018
- People with metastatic melanoma and initially Vitamin D deficient had 4.7 times worse outcome if not get enough D – Dec 2016
Items in both categories Cancer-Skin and Vitamin D Receptor:
- Book: Sunlight, UV, Vitamin D and Receptor, Skin and other Cancers - Dec 2020
- Melanoma cancer growth slowed by increased Vitamin D Receptor (yet again) – Oct 2019
- Nonmelanoma Skin Cancer 2X more likely if poor Vitamin D Receptor – Oct 2017
- UVB improvements to Vitamin D receptor appear to improve melanoma survival – Oct 2017
- Skin Cancers, Vitamin D, Vitamin D Receptor and Genes – Jan 2015
- Malignant melanoma may be reduced by skin-activated vitamin D – Nov 2016
- Skin cancer 20 percent more likely with some Vitamin D receptor gene polymorphisms – Oct 2015
- Death from melanoma (without ulcers) greatly decreased if have lots of vitamin D receptors – May 2014
- Melanoma risk 2X to 4X higher if Vitamin D receptor genes had morphed – March 2014
- Vitamin D receptor may suppress skin cancer – Dec 2013
46+ VitaminDWiki pages have MELANOMA in the title
This list is automatically updated
Download the PDF from VitaminDWiki
Patients afflicted with melanoma show lower vitamin D serum levels (VDSL) than the healthy population. This hypothesis agrees with its well-known antiproliferative features. An observational study was carried out to collect VDSL in patients suffering from melanoma. Our aim was to identify a potential connection between low VDSL and the risk to incur melanoma. Furthermore, we studied the association between VDSL at the diagnosis of melanoma and other germane prognostic factors. The population held in regard was composed of 154 patients with a diagnosis of melanoma between 2016 and 2019. These patients were retrospectively collected from our follow-up storage. We compared VDSL to clinical and pathological parameters (age, sex, tumour location, Breslow's depth, Clark's level, histological subtype, ulceration, et aliqua). Moreover, we recruited a control group with negative melanoma history. Mean and median of VDSL were significantly lower in the melanoma group.
Instead, we found a negative association between melanoma and VDSL > 30 ng/L (OR 0.11; p < 0.0001). No correlation between VDSL and both Breslow's depth and Clark's level was discovered, but the VDSL comparison between thin (depth ≤ 1 mm) and thick tumours (depth > 1 mm) revealed a statistically significant difference (21.1 ± 8.2 ng/L vs 17.8 ± 8.1; p = 0.01). Moreover, VDSL were significantly lower in melanomas with mitotic rate ≥ 1/mm2 (22.1 ± 8.3 ng/L; p < 0007). Nevertheless, no connection was found between VDSL and both ulceration and positive sentinel nodes (p = 0.76; p = 0.74). Besides, our study revealed no association between VDSL and histological subtype (p = 0.161). Lower VDSL correlate with thick and high mitotic rate tumours. Future prospective studies would investigate if appropriate upkeep of suitable VDSL can decrease the risk of primary and recurrent melanoma diagnosis.
| 3467 visitors, last modified 14 Feb, 2024, |
| ID | Name | Uploaded | Size | Downloads | |
|---|---|---|---|---|---|
| 15247 | Melanoma table.jpg | admin 13 Mar, 2021 | 86.69 Kb | 373 | |
| 15246 | melanoma vs control.jpg | admin 13 Mar, 2021 | 37.05 Kb | 364 | |
| 15245 | Melanoma prevention with Vitamin D.pdf | admin 13 Mar, 2021 | 1.13 Mb | 534 |